Xiangyang Zhang
Chairman @ Haitong Capital
Shanghai, China
Xiangyang Zhang is a Series B investor at Haitong Capital in Shanghai focused on Health Care and Biotechnology. Xiangyang Zhang - Chairman @ Haitong Capital
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Xiangyang Zhang invests in
Stages Xiangyang Zhang invests in
Countries Xiangyang Zhang invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (67%)
- Biotechnology 2 (67%)
- Pharmaceutical 2 (67%)
- Biopharma 1 (33%)
- Clinical Trials 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Tejin Intelligence is deeply involved in radio sensing and spectrum big data analysis technology, and is dedicated to providing the world's leading low-altitude safety management and control solutions, assisting in the development of new ground-air integrated three-dimensional security infrastructure for smart cities, and striving for refinedmanagement of urban low-altitude airspace. | Series B / Feb 24, 2025 | ||
| Healsun Biopharm is a pharmaceutical company development processes such as molecular construction, stable cell line screening, cell culture process development, protein purification and process development, antibody-coupled drug process development and bioanalytical method development. | $36.8M / Series B / Aug 18, 2022 | ||
| Gensciences develops drugs that focus on underserved illnesses like hemophilia, metabolic diseases, and anti-tumor fields. | $123.6M / Series B / Mar 04, 2021 |
Co-Investors
About Haitong Capital
Haitong Capital is a private investment firm focuses on growing small and medium-sized companies. It is a wholly-owned subsidiary of Haitong Securities and an investment management platform for private equity investment business. Haitong Capital focuses on and tracks growing small and medium-sized companies with good integrity records, mature business models and unique core competencies.
Haitong Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Wu Min
CEO
|
|||
|
Xiangyang Zhang
Chairman
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Xiangyang Zhang invest in?
Xiangyang Zhang invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series B stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Xiangyang Zhang?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Xiangyang Zhang last invest?
The most recent investment recorded for Xiangyang Zhang closed in Feb 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
